During the past decade, Texas Cardiac Arrhythmia Institute, St. David's Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center" #1 sponsor was "Texas Cardiac Arrhythmia Research Foundation" with 20 trials, followed by "Biosense Webster, Inc." with 2 trials sponsored, "nContact Surgical Inc." with 2 trials sponsored, "Cardiva Medical, Inc." with 1 trials sponsored and "Catholic University of the Sacred Heart" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center" #1 collaborator was "California Pacific Medical Center" with 2 trials as a collaborator, "Ospedale dell'Angelo, Venezia-Mestre" with 2 trials as a collaborator, "Texas Cardiac Arrhythmia Research Foundation" with 2 trials as a collaborator, "University of Texas at Austin" with 2 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center" are "Atrial Fibrillation" (14 trials), "Ventricular Tachycardia" (3 trials), "COVID-19" (2 trials), "Paroxysmal Atrial Fibrillation" (2 trials) and "Persistent Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center" in a lesser frequency.

Most popular intervention types in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center" are "Procedure" (14 trials), "Device" (11 trials), "Diagnostic Test" (2 trials), "Drug" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Catheter ablation" (3 trials), "Half-normal saline" (2 trials), "Normal saline" (2 trials), "Numeris®-AF Guided Coagulation System with VisiTrax®" (2 trials) and "radiofrequency catheter ablation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 7 active trials in "Texas Cardiac Arrhythmia Institute, St. David's Medical Center". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".